Christine Macie, Kate Wooldrage, Jure Manfreda, Nicholas AnthonisenDepartment of Medicine, University of Manitoba, Winnipeg, Manitoba, CanadaAbstract: We used the Manitoba Health database to examine the relationship between use of inhaled respiratory drugs in people with chronic obstructive respiratory diseases and cardiovascular hospitalizations from 1996 through 2000. The drugs examined were beta agonists [BA], ipratropium bromide IB, and inhaled steroids (ICS). End points were first hospitalizations for supraventricular tachycardia, myocardial infarction, heart failure or stroke. A nested case control analysis was employed comparing people with and without cardiovascular events. Cases and controls were matched for gender and age, and con...
Study ObjectiveInhaled long-acting bronchodilators are commonly used as maintenance therapy in chron...
Chronic obstructive pulmonary disease (COPD) is a substantial health burden. Cardiovascular disease ...
Chronic obstructive pulmonary disease (COPD) is the most common chronic respiratory disease and its ...
Background: Globally, cardiovascular disease (CVD) is the leading cause of death. Beta-blocker medic...
Objectives: Long-acting bronchodilators are mainstay treatment for moderate to severe chronic obstru...
BACKGROUND: While inhaled bronchodilators reduce symptoms and acute exacerbations of chronic obstruc...
Whereas first line therapy for chronic obstructive pulmonary disease (COPD) usually includes a short...
[[abstract]]Background: To determine the effects of bronchodilator, steroid, and anti-arrhythmia dru...
Introduction: Chronic obstructive pulmonary disease (COPD) therapy includes a multi-dimensional appr...
Context Inhaled anticholinergics (ipratropium bromide or tiotropium bromide) are widely used in pati...
Individuals with chronic respiratory disorder often have cardiovascular comorbidities and are more v...
Purpose: Despite ample evidence underpinning the efficacy of β2-agonists in asthma and chronic obstr...
Coronary atherosclerosis and chronic obstructive pulmonary disease (COPD) are highly prevalent, and...
risk for major cardiovascular events in chronic obstructive pulmonary disease* Singh S, Loke YK, Fur...
Rationale: Cardiovascular disease is a common comorbidity in patients with chronic obstructive pulmo...
Study ObjectiveInhaled long-acting bronchodilators are commonly used as maintenance therapy in chron...
Chronic obstructive pulmonary disease (COPD) is a substantial health burden. Cardiovascular disease ...
Chronic obstructive pulmonary disease (COPD) is the most common chronic respiratory disease and its ...
Background: Globally, cardiovascular disease (CVD) is the leading cause of death. Beta-blocker medic...
Objectives: Long-acting bronchodilators are mainstay treatment for moderate to severe chronic obstru...
BACKGROUND: While inhaled bronchodilators reduce symptoms and acute exacerbations of chronic obstruc...
Whereas first line therapy for chronic obstructive pulmonary disease (COPD) usually includes a short...
[[abstract]]Background: To determine the effects of bronchodilator, steroid, and anti-arrhythmia dru...
Introduction: Chronic obstructive pulmonary disease (COPD) therapy includes a multi-dimensional appr...
Context Inhaled anticholinergics (ipratropium bromide or tiotropium bromide) are widely used in pati...
Individuals with chronic respiratory disorder often have cardiovascular comorbidities and are more v...
Purpose: Despite ample evidence underpinning the efficacy of β2-agonists in asthma and chronic obstr...
Coronary atherosclerosis and chronic obstructive pulmonary disease (COPD) are highly prevalent, and...
risk for major cardiovascular events in chronic obstructive pulmonary disease* Singh S, Loke YK, Fur...
Rationale: Cardiovascular disease is a common comorbidity in patients with chronic obstructive pulmo...
Study ObjectiveInhaled long-acting bronchodilators are commonly used as maintenance therapy in chron...
Chronic obstructive pulmonary disease (COPD) is a substantial health burden. Cardiovascular disease ...
Chronic obstructive pulmonary disease (COPD) is the most common chronic respiratory disease and its ...